GNAT2
protein-codingG protein subunit alpha transducin 2, the group of G protein subunits alpha, group i
Gene summary
Transducin is a 3-subunit guanine nucleotide-binding protein (G protein) which stimulates the coupling of rhodopsin and cGMP-phoshodiesterase during visual impulses. The transducin alpha subunits in rods and cones are encoded by separate genes. This gene encodes the alpha subunit in cones. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~16.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013465
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0800392
Submitter: ClinGen
*GNAT2* was first reported in relation to autosomal recessive cases of achromatopsia 4 (ACHM) in 2002 (PMID: 12077706). In the complete form of ACHM, affected individuals typically present early in life with nystagmus, photophobia, low visual acuity, and total color blindness. Electroretinographic recordings (ERG) show an absent photopic and a normal scotopic response in affected individuals. Some individuals show residual color vision and slightly better visual acuity leading to a clinical diagnosis of incomplete ACHM. Because of the broad spectrum of potential phenotypes, these cases with causal variants in *GNAT2* have been curated under the inclusive disease name *GNAT2*-related retinopathy (MONDO:0800392). Ten suspected pathogenic variants were scored as part of this curation (four nonsense, two missense and four frameshift), which have been reported among twelve probands in seven publications (PMIDs:12077706, 12205108, 31058429, 27718025, 21107338, 32203983, 28041643). The mechanism of pathogenicity appears to be biallelic loss-of-function. Additionally, segregation data from two publications (PMIDs: 12205108, 21107338) were scored. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease association is also supported by experimental evidence that *GNAT2* is expressed in retina photoreceptor cells of developing zebrafish embryos (PMID: 22815753). A mouse model with a homozygous *GNAT2* mutation was shown to have little or no light-adapted (cone-mediated) ERG response and poor visual acuity, similar to observations in the human form of complete achromatopsia. Using AAV gene therapy to inject wild-type *GNAT2* cDNA into the retina of the mutated mice, the ERG response and visual acuity phenotypes were rescued (PMID: 17515894). In a naturally occurring mouse model with a different *GNAT2* mutation, affected mice displayed no cone ERG response, showed evidence of altered transducin protein structure and M-opsin mislocalization, and developed cone degeneration by 12 months of age (PMID: 23580486). In summary, *GNAT2* is definitively associated with autosomal recessive inheritance of *GNAT2*-related retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time without the emergence of contradictory evidence, leading to a Definitive classification according to the ClinGen template. This classification was approved by the ClinGen Retina GCEP on November 3rd, 2022 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0013465
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013465
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013465
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0018852
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0000455
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GNAT2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001377295.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 55 | 61 | |||
| missense | 2 | 4 | 115 | 8 | 1 | 130 |
| nonsense | 5 | 4 | 9 | |||
| start loss | 1 | 1 | ||||
| frameshift | 11 | 6 | 1 | 18 | ||
| splice donor/acceptor (+/-2bp) | 3 | 9 | 12 | |||
| Total | 21 | 24 | 122 | 63 | 1 | 231 |
Highest pathogenic variant AF is 0.000014881488
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001364224.1 | 8 | MANE Select | |
| Ensembl | ENSP00000505083.1 | 8 | MANE Select | |
| RefSeq | NP_001366161.1 | 8 | Standard | |
| RefSeq | NP_005263.1 | 8 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| gnat2 | Danio rerio | Structure: melanocyte Quality: morphology abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Phototransduction - Homo sapiens (human)
- Signaling by GPCR
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
- Signaling by WNT
- Signal Transduction
Biological Process
- detection of chemical stimulus involved in sensory perception of bitter taste
- protein folding
- G protein-coupled receptor signaling pathway
- adenylate cyclase-modulating G protein-coupled receptor signaling pathway
- positive regulation of cytosolic calcium ion concentration
Molecular Function
- G protein-coupled receptor binding
- GTPase activity
- GTP binding
- G protein-coupled photoreceptor activity
- G-protein beta/gamma-subunit complex binding
Cellular Component
- photoreceptor outer segment
- photoreceptor inner segment
- heterotrimeric G-protein complex
- plasma membrane
- photoreceptor outer segment membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000351050
- Coding exons
- 8
- Length
- 9791
- Individuals with no LoFs
- 125718
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 30
- Defined
- 125748
- p
- 0.000119
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.663 | 161 | 186 | 0.863 | 0.0000102 | 2372 |
| Missense (PolyPhen) | 71 | 82.227 | 0.86347 | 1099 | ||
| Synonymous | 0.0217 | 71 | 71.2 | 0.997 | 0.00000418 | 636 |
| Loss of Function | 1.62 | 11 | 18.6 | 0.593 | 0.00000118 | 215 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00011 | 0.00011 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. Transducin is an amplifier and one of the transducers of a visual impulse that performs the coupling between rhodopsin and cGMP-phosphodiesterase.;
Recessive Scores
- pRec
- 0.168
Intolerance Scores
- LoFtool
- 0.303
- RVIS EVS
- 0.02
- RVIS percentile EVS
- 55.22
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0545
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |